首页> 美国卫生研究院文献>LGBT Health >The Relationship Between Tobacco Use and Legal Document Gender-Marker Change Hormone Use and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health
【2h】

The Relationship Between Tobacco Use and Legal Document Gender-Marker Change Hormone Use and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health

机译:美国跨性别女性和跨男性个体样本中烟草使用与法律文件中的性别标记变化激素使用和性别确认手术之间的关系:对心血管健康的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: Transgender individuals smoke tobacco at disproportionately higher rates than the general U.S. population, and concurrent use of gender-affirming hormones (estrogen or testosterone) and tobacco confers greater cardiovascular (CV) risk. This study examines the relationship between tobacco use and legal document gender-marker change, and medical/surgical interventions for gender transition.>Methods: Data came from an Internet-based survey of U.S. trans-feminine (n = 631) and trans-masculine (n = 473) individuals. We used multivariable logistic regression to investigate the relationship between past 3-month tobacco use and legal document gender-marker change, hormone use, and gender-affirming surgery controlling for demographic covariates and enacted and felt stigma.>Results: Compared to trans-feminine participants, trans-masculine individuals reported significantly higher rates of lifetime (74.4% vs. 63.5%) and past 3-month tobacco use (47.8% vs. 36.1%), and began smoking at an earlier age (14.5 vs. 15.5 years). Trans-feminine smokers reported significantly more frequent and heavier use. Adjusting for demographic covariates and enacted and felt stigma, legal document gender-marker change was associated with lower tobacco-use odds among trans-feminine individuals, whereas gender-affirming surgery predicted lower smoking odds among trans-masculine individuals. There were no significant differences in tobacco use by hormone use status.>Conclusion: In this study, trans-masculine individuals were more likely to smoke and trans-feminine individuals reported heavier use. It is concerning that individuals receiving hormones did not report lower smoking rates, given the elevated CV risk of this combination. This is a missed opportunity to intervene on a major public health issue and highlights the need for smoking cessation interventions in this population.
机译:>目的:跨性别者吸烟的比例比美国普通人群高得多,并且同时使用肯定性别的激素(雌激素或睾丸激素)和烟草会增加心血管(CV)风险。这项研究研究了烟草使用和法律文件中性别标记的变化以及性别过渡的医学/手术干预之间的关系。>方法:数据来自基于互联网的美国跨性别女性调查(n = 631)和反男性(n = 473)。我们使用多变量logistic回归研究过去3个月的烟草使用量与法律文件中的性别标记变化,激素使用情况以及控制性别的手术(控制人口统计学变量以及已制定和感到的耻辱)之间的关系。>结果:与跨性别女性相比,跨男性个体的终生发生率(74.4%比63.5%)和过去3个月的吸烟率(47.8%比36.1%)明显更高,并且开始吸烟的年龄更早( 14.5年和15.5年)。跨女性吸烟者报告说更频繁,更重度使用。调整人口统计学变量并制定和感到耻辱后,法律文件中性别标记的变化与跨女性之间的烟草使用几率降低相关,而确认性别的手术预测跨男性之间的吸烟几率降低。 <激素>结论:在这项研究中,跨男性人群吸烟的可能性更高,而跨女性人群吸烟的比例更高。令人担忧的是,考虑到服用这种激素的心血管风险升高,接受激素治疗的人并未报告吸烟率较低。这是在重大公共卫生问题上进行干预的错失良机,并突出显示了对该人群进行戒烟干预的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号